Meiragtx Holdings Plc(MGTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MGTX Meiragtx Holdings Plc

Pre-Market Trading 06-18 06:37:45 EDT

4.39

-0.10

-2.23%

High4.54	Low4.33	Vol258.04K
Open4.48	D1 Closing4.49	Amplitude4.68%
Mkt Cap282.31M	Tradable Cap113.26M	Total Shares64.31M
T/O1.13M	T/O Rate1.00%	Tradable Shares25.80M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"MGTX","market":"US","secType":"STK","nameCN":"Meiragtx Holdings Plc","latestPrice":4.39,"timestamp":1718654400000,"preClose":4.49,"halted":0,"volume":258040,"delay":0,"floatShares":25799871,"shares":64306613,"eps":-1.232485,"marketStatus":"Pre-Market Trading","change":-0.1,"latestTime":"06-18 06:37:45 EDT","open":4.48,"high":4.54,"low":4.33,"amount":1133871.1482,"amplitude":0.046771,"askPrice":7.02,"askSize":200,"bidPrice":3.2,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.232485,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1718717400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1528430400000,"exchange":"NASDAQ","adjPreClose":4.39,"postHourTrading":{"tag":"盘后","latestPrice":4.48,"preClose":4.39,"latestTime":"18:48 EDT","volume":2829,"amount":12428.34,"timestamp":1718664524941},"volumeRatio":1.770070487954876,"impliedVol":0.8383,"impliedVolPercentile":0.502},"requestUrl":"/m/hq/s/MGTX/tweets","defaultTab":"tweets","newsList":[{"id":"2439620219","title":"Here's Why It's Unlikely That MeiraGTx Holdings plc's (NASDAQ:MGTX) CEO Will See A Pay Rise This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2439620219","media":"Simply Wall St.","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2439620219?lang=en_us&edition=fundamental","pubTime":"2024-05-31 19:11","pubTimestamp":1717153869,"startTime":"0","endTime":"0","summary":"MeiraGTx Holdings will host its Annual General Meeting on 6th of June. CEO Alexandria Forbes' total compensation includes salary of US$648.0k. MeiraGTx Holdings' three-year loss to shareholders was 66% while its EPS was down 4.8% over the past three years. Shareholders will probably not be too impressed with the underwhelming results at MeiraGTx Holdings plc  recently. Shareholders will be interested in what the board will have to say about turning performance around at the next AGM on 6th of June. It would also be an opportunity for shareholders to influence management through voting on company resolutions such as executive remuneration, which could impact the firm significantly. The data we present below explains why we think CEO compensation is not consistent with recent performance.Comparing MeiraGTx Holdings plc's CEO Compensation With The Industry. Has MeiraGTx Holdings plc Been A Good Investment?","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-unlikely-meiragtx-holdings-111109159.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NDAQ","QQQ","BK4139","TQQQ","QLD","LU2095319765.USD","LU2210149790.SGD",".IXIC","MNQmain","BK4112","QID","BK4585","SQQQ","LU2210150020.SGD","MGTX","PSQ","NQmain","BK4588"],"gpt_icon":0},{"id":"2437959952","title":"Jim Cramer is Recommending These Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2437959952","media":"Insider Monkey","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2437959952?lang=en_us&edition=fundamental","pubTime":"2024-05-22 21:32","pubTimestamp":1716384767,"startTime":"0","endTime":"0","summary":"Jim Cramer in a recent program talked about the importance of The Dow Jones Industrial Average touching the 40,000 mark for the first time ever. Cramer said that the Dow hitting its new highs was a \"team effort\" with stocks from many different sectors adding to the index's gains, instead of just the gains from major tech stocks with size and growth similar to the likes of NVIDIA Corp , Amazon.com Inc  and Alphabet .Cramer said that many of the Dow stocks should have been \"hurt\" by the consistent rate hikes by the Fed.\"They should have been crushed by the inflationary spiral. They should have been annihilated by supply chain problems during COVID. None of that happened.\". Cramer Doesn't See \"Anything\" Like 2008 Crisis Happening. Cramer said that it's been almost 20 years since the 2008 financial crisis. When he \"surveys\" today's market \"landscape\" he sees the situation totally different from what it was back then.Cramer said that many people would argue that no one saw the 2008 financia","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/x6X2s4PHR4Prg4iHQ7QqKw--~B/aD04MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/d246300e28cb36eea299b67b3e75789d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/x6X2s4PHR4Prg4iHQ7QqKw--~B/aD04MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/d246300e28cb36eea299b67b3e75789d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jim-cramer-recommending-stocks-133247669.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0149725797.USD","QID","BROS","LU0289739343.SGD","SQQQ","BK4573","NVDA","BK4141","PSQ","QQQ","GOOG","BK4581","LU1316542783.SGD","LU1803068979.SGD","BK4585","MNQmain","LU0048573561.USD","LU0310800965.SGD","BK4507","LU0289961442.SGD","BK4587","IE00BD6J9T35.USD","LU0056508442.USD","LU0109392836.USD","ANF","BK4077","BK4576","BK4503","LU0289941410.SGD","BK4579","TQQQ","QLD","MGTX","AMZN","BK4588","LU0310799852.SGD","SFM","GOOGL","LU0175139822.USD","LU0198837287.USD","BK4574","NQmain","LU0642271901.SGD","BK4592","LU1839511570.USD",".IXIC","LU0444971666.USD","LU0557290698.USD","IE00BMPRXN33.USD","IE0034235188.USD"],"gpt_icon":1},{"id":"2435326836","title":"Analyst Forecasts For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2435326836","media":"Simply Wall St.","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2435326836?lang=en_us&edition=fundamental","pubTime":"2024-05-13 18:40","pubTimestamp":1715596823,"startTime":"0","endTime":"0","summary":"MeiraGTx Holdings plc  shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The analysts greatly increased their revenue estimates, suggesting a stark improvement in business fundamentals.Following the upgrade, the most recent consensus for MeiraGTx Holdings from its three analysts is for revenues of US$70m in 2024 which, if met, would be a huge increase on its sales over the past 12 months. Losses are supposed to balloon 34% to US$1.55 per share. Yet prior to the latest estimates, the analysts had been forecasting revenues of US$56m and losses of US$1.76 per share in 2024. So there's been quite a change-up of views after the recent consensus updates, with the analysts making a sizeable increase to their revenue forecasts while also reducing the estimated loss as the business grows towards breakeven.Of course, seeing company management  invest large sums of money in a stock can be just as useful as knowing whe","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/analyst-forecasts-meiragtx-holdings-plc-104023489.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NQmain","BK4112","SQQQ","MNQmain","BK4585","MGTX","LU2210150020.SGD","TQQQ","PSQ","QLD","NDAQ","QQQ","BK4588","LU2210149790.SGD",".IXIC","QID","BK4139","LU2095319765.USD"],"gpt_icon":0},{"id":"2434893011","title":"MeiraGTx Holdings PLC Reports First Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2434893011","media":"GuruFocus.com","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2434893011?lang=en_us&edition=fundamental","pubTime":"2024-05-11 03:09","pubTimestamp":1715368143,"startTime":"0","endTime":"0","summary":"Revenue: Reported at $0.7 million for Q1 2024, a significant decrease from $3.3 million in Q1 2023, falling short of the estimated $0.69 million.Net Loss: Recorded a net loss of $20.4 million in Q1 2024, improving from a net loss of $30.4 million in Q1 2023, but still exceeds the estimated net loss of $31.94 million.Earnings Per Share : Reported a loss of $0.32 per share, surpassing the estimated loss of $0.51 per share.Research and Development Expenses: Increased significantly to $34.3 million in Q1 2024 from $22.3 million in Q1 2023, reflecting ongoing investment in clinical programs.Cash Position: Ended the quarter with $119.2 million in cash and cash equivalents, down from $130.6 million at the end of 2023.Financial Outlook: Expects sufficient capital to fund operations into Q1 2026, not including potential milestone payments of $285 million related to bota-vec commercial sales.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/J7ABjfrDObwjER9m1DQ.2w--~B/aD01NTc7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/3d3b790b3324ff742885b51da1d91901","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/J7ABjfrDObwjER9m1DQ.2w--~B/aD01NTc7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/3d3b790b3324ff742885b51da1d91901"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/meiragtx-holdings-plc-reports-first-190903704.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MGTX","BK4139"],"gpt_icon":0},{"id":"2434085853","title":"MeiraGTx Holdings First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.62 loss in 1Q 2023)","url":"https://stock-news.laohu8.com/highlight/detail?id=2434085853","media":"Simply Wall St.","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2434085853?lang=en_us&edition=fundamental","pubTime":"2024-05-10 19:54","pubTimestamp":1715342047,"startTime":"0","endTime":"0","summary":"NasdaqGS:MGTX Earnings and Revenue Growth May 10th 2024. All figures shown in the chart above are for the trailing 12 month  period. Looking ahead, revenue is forecast to grow 47% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Biotechs industry in the US.The company's shares are up 2.0% from a week ago.It's necessary to consider the ever-present spectre of investment risk.   We've identified 2 warning signs  with MeiraGTx Holdings , and understanding these should be part of your investment process.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/meiragtx-holdings-first-quarter-2024-115407812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MGTX"],"gpt_icon":0},{"id":"2434301623","title":"MeiraGTx GAAP EPS of -$0.32, revenue of $0.69M","url":"https://stock-news.laohu8.com/highlight/detail?id=2434301623","media":"seekingalpha","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2434301623?lang=en_us&edition=fundamental","pubTime":"2024-05-09 22:36","pubTimestamp":1715265400,"startTime":"0","endTime":"0","summary":"MeiraGTx press release  (NASDAQ:MGTX): Q1  GAAP EPS of -$0.32.\nRevenue of $0.69M.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4103767-meiragtx-gaap-eps-of-0_32-revenue-of-0_69m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["MGTX","BK4139"],"gpt_icon":0},{"id":"2434016122","title":"MeiraGTx Holdings PLC reports results for the quarter ended in March - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2434016122","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2434016122?lang=en_us&edition=fundamental","pubTime":"2024-05-09 22:34","pubTimestamp":1715265259,"startTime":"0","endTime":"0","summary":"* MeiraGTx Holdings PLC    reported a quarterly adjusted loss of 32 cents per share for the quarter ended in March, higher than the same quarter last year, when the company reported EPS of -62 cents. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX"],"gpt_icon":0},{"id":"2434978870","title":"MeiraGTx Hldgs Q1 EPS $(0.32) Beats $(0.50) Estimate, Sales $697.00K Down From $3.33M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2434978870","media":"Benzinga","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2434978870?lang=en_us&edition=fundamental","pubTime":"2024-05-09 21:01","pubTimestamp":1715259661,"startTime":"0","endTime":"0","summary":"MeiraGTx Hldgs (NASDAQ:MGTX) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.50) by 36 percent. This is a 48.39 percent increase over losses of $(0.62) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38731160/meiragtx-hldgs-q1-eps-0-32-beats-0-50-estimate-sales-697-00k-down-from-3-33m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX"],"gpt_icon":0},{"id":"2433202522","title":"MeiraGTx Holdings PLC    expected to post a loss of 50 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2433202522","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2433202522?lang=en_us&edition=fundamental","pubTime":"2024-05-07 21:16","pubTimestamp":1715087792,"startTime":"0","endTime":"0","summary":"* MeiraGTx Holdings PLC     is expected to show a rise in quarterly revenue when it reports  results on May 9 (estimated) for the period ending March 31 2024   * The New York City-based  company is ex","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX"],"gpt_icon":0},{"id":"2430893401","title":"MeiraGTx Holdings plc (NASDAQ:MGTX): Is Breakeven Near?","url":"https://stock-news.laohu8.com/highlight/detail?id=2430893401","media":"Simply Wall St.","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2430893401?lang=en_us&edition=fundamental","pubTime":"2024-04-25 19:41","pubTimestamp":1714045288,"startTime":"0","endTime":"0","summary":"MeiraGTx Holdings plc  is possibly approaching a major achievement in its business, so we would like to shine some light on the company. MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The US$317m market-cap company announced a latest loss of US$84m on 31 December 2023 for its most recent financial year result. As path to profitability is the topic on MeiraGTx Holdings' investors mind, we've decided to gauge market sentiment. Below we will provide a high-level summary of the industry analysts’ expectations for the company.MeiraGTx Holdings is bordering on breakeven, according to the 3 American Biotechs analysts. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$133m in 2025. So, the company is predicted to breakeven just over a year from now. How fast will the company have to grow each year in order to reach the breakeven point by 2025?Working backwards ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/meiragtx-holdings-plc-nasdaq-mgtx-114128191.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NDAQ","BK4588","LU2095319765.USD","LU2210149790.SGD","QQQ","MGTX","QLD","BK4585","NQmain","TQQQ","BK4112","BK4139","MNQmain","QID",".IXIC","SQQQ","LU2210150020.SGD","PSQ"],"gpt_icon":0},{"id":"2430951444","title":"MeiraGTx to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2430951444","media":"GlobeNewswire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2430951444?lang=en_us&edition=fundamental","pubTime":"2024-04-25 04:30","pubTimestamp":1713990600,"startTime":"0","endTime":"0","summary":"LONDON and NEW YORK, April 24, 2024  -- MeiraGTx Holdingsplc, a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., President and Chief Executive Officer, will participate in the following investor conferences:. Chardan 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit, Virtual. Goldman Sachs 45th Annual Global Healthcare Conference, Miami. Corporate presentation: Wednesday, June 12, 2024, at 2:40 p.m. ET","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/8wKC2FWfAsb3K9HApbTCpQ--~B/aD04MDt3PTQwNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7d3a2fa2ab3c203b44f402dd7f69c584","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/8wKC2FWfAsb3K9HApbTCpQ--~B/aD04MDt3PTQwNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/7d3a2fa2ab3c203b44f402dd7f69c584"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/meiragtx-participate-upcoming-investor-conferences-203000415.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","MGTX"],"gpt_icon":0},{"id":"2419924647","title":"RBC Capital Sticks to Their Buy Rating for Meiragtx Holdings (MGTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2419924647","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2419924647?lang=en_us&edition=fundamental","pubTime":"2024-03-15 18:47","pubTimestamp":1710499623,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Luca Issi maintained a Buy rating on Meiragtx Holdings (MGTX – Research Report) yesterday and set a price target of $11.00. The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-meiragtx-holdings-mgtx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-meiragtx-holdings-mgtx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4207","BK4139","MGTX"],"gpt_icon":0},{"id":"2419985044","title":"MeiraGTx Holdings PLC Reports Notable Clinical Progress Amidst Financial Challenges in 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2419985044","media":"GuruFocus.com","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2419985044?lang=en_us&edition=fundamental","pubTime":"2024-03-14 22:31","pubTimestamp":1710426718,"startTime":"0","endTime":"0","summary":"Cash Position: Cash and cash equivalents increased to $129.6 million as of December 31, 2023, from $115.5 million the previous year.License Revenue: License revenue decreased slightly to $14.0 million in 2023 from $15.9 million in 2022.Operating Expenses: Research and development expenses rose to $103.8 million, while general and administrative expenses saw a marginal increase to $47.3 million in 2023.Net Loss: Net loss attributable to ordinary shareholders improved to $84.0 million, or $1.49 per share, compared to a net loss of $129.6 million, or $2.87 per share in 2022.Gain on Sale of Assets: A significant gain of $54.2 million was recorded from the sale of nonfinancial assets to Janssen.GuruFocus has detected 6 Warning Signs with MGTX.On March 14, 2024, MeiraGTx Holdings PLC , a clinical-stage gene therapy company, released its 8-K filing, detailing its financial and operational results for the fourth quarter and the full year ended December 31, 2023. The company, which focuses on d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/meiragtx-holdings-plc-reports-notable-143158592.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4097","PRGS","MGTX","BK4139","LU2065732104.USD"],"gpt_icon":0},{"id":"2419001356","title":"MeiraGTx Holdings PLC reports results for the quarter ended in December - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2419001356","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2419001356?lang=en_us&edition=fundamental","pubTime":"2024-03-14 22:20","pubTimestamp":1710426026,"startTime":"0","endTime":"0","summary":"* MeiraGTx Holdings PLC    reported a quarterly adjusted loss of 42 cents per share for the quarter ended in December, higher than the same quarter last year, when the company reported EPS of -60 cent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX"],"gpt_icon":0},{"id":"2419989973","title":"MeiraGTx Holdings PLC (MGTX) Reports Q4 Loss, Misses Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2419989973","media":"Zacks","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2419989973?lang=en_us&edition=fundamental","pubTime":"2024-03-14 21:45","pubTimestamp":1710423902,"startTime":"0","endTime":"0","summary":"MeiraGTx Holdings PLC  came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to loss of $0.58 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -2.17%. A quarter ago, it was expected that this company would post a loss of $0.63 per share when it actually produced a loss of $0.74, delivering a surprise of -17.46%.Over the last four quarters, the company has surpassed consensus EPS estimates two times.MeiraGTx Holdings PLC , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $2.04 million for the quarter ended December 2023, missing the Zacks Consensus Estimate by 79.86%. This compares to year-ago revenues of $-5.29 million. The company has topped consensus revenue estimates just once over the last four quarters.Investors should be mindful of the fact that the outlook for the industry can have a material i","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/hYDVEF34jJNULlluFRTwjg--~B/aD05MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/hYDVEF34jJNULlluFRTwjg--~B/aD05MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/meiragtx-holdings-plc-mgtx-reports-134502725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MGTX"],"gpt_icon":0},{"id":"2419560307","title":"Press Release: MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2419560307","media":"Dow Jones","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2419560307?lang=en_us&edition=fundamental","pubTime":"2024-03-14 20:30","pubTimestamp":1710419400,"startTime":"0","endTime":"0","summary":"MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates. - Company aligned with FDA on requirements for ongoing Phase 2 AQUAx2 clinical trial for Grade 2/3 radiation-induced xerostomia to be considered pivotal supporting potential BLA filing. - Company to present data from the Phase 1 AQUAx study in an oral presentation at the American Academy of Oral Medicine 2024 annual meeting  April 17-20, 2024. - Completed dosing the three-arm randomized, sham-controlled Phase 1 clinical bridging study for AAV-GAD for the treatment of Parkinson's disease. - Company to present positive data on AAV-AIPL1 treatment of 8 LCA4 patients each with meaningful responses in second quarter 2024. - Entered into an asset purchase agreement with Janssen Pharmaceuticals, Inc.  related to botaretigene sparoparvovec  for the treatment of X-linked retinitis pigmentosa  for up to $415 million, as well as a commercial supply agreement pursuant to which the Comp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX","BK4135","BK4139","CNS"],"gpt_icon":0},{"id":"2417058024","title":"MeiraGTx Holdings PLC    expected to post a loss of 11 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2417058024","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2417058024?lang=en_us&edition=fundamental","pubTime":"2024-03-08 20:32","pubTimestamp":1709901168,"startTime":"0","endTime":"0","summary":"* MeiraGTx Holdings PLC     is expected to report resultson March 12 (estimated) for the period ending December 31 2023   * The New York City-based  company is expected to report revenue of $6.563 mil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.meiragtx.com","stockEarnings":[{"period":"1week","weight":-0.0854},{"period":"1month","weight":-0.2312},{"period":"3month","weight":-0.301},{"period":"6month","weight":-0.1059},{"period":"1year","weight":-0.4154},{"period":"ytd","weight":-0.3746}],"compareEarnings":[{"period":"1week","weight":0.0214},{"period":"1month","weight":0.0333},{"period":"3month","weight":0.0609},{"period":"6month","weight":0.1684},{"period":"1year","weight":0.2449},{"period":"ytd","weight":0.151}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. The company was incorporated in 2015 and is based in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.014395},{"month":2,"riseRate":0.5,"avgChangeRate":0.023237},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.086393},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.037019},{"month":5,"riseRate":0.666667,"avgChangeRate":0.038447},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.006024},{"month":7,"riseRate":0.5,"avgChangeRate":-0.035193},{"month":8,"riseRate":0.5,"avgChangeRate":-0.016076},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.029811},{"month":10,"riseRate":0.166667,"avgChangeRate":0.044974},{"month":11,"riseRate":0.666667,"avgChangeRate":0.045692},{"month":12,"riseRate":0.833333,"avgChangeRate":0.095122}],"exchange":"NASDAQ","name":"Meiragtx Holdings Plc","nameEN":"Meiragtx Holdings Plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.0","shortVersion":"4.24.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Meiragtx Holdings Plc(MGTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Meiragtx Holdings Plc(MGTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Meiragtx Holdings Plc,MGTX,Meiragtx Holdings Plc股票,Meiragtx Holdings Plc股票老虎,Meiragtx Holdings Plc股票老虎国际,Meiragtx Holdings Plc行情,Meiragtx Holdings Plc股票行情,Meiragtx Holdings Plc股价,Meiragtx Holdings Plc股市,Meiragtx Holdings Plc股票价格,Meiragtx Holdings Plc股票交易,Meiragtx Holdings Plc股票购买,Meiragtx Holdings Plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Meiragtx Holdings Plc(MGTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Meiragtx Holdings Plc(MGTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction